Friday, September 19, 2025 9/19/2025

Mitochondrial signaling dynamics in cocaine use disorder

Award Number: DP1DA058362
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/15/2023
PERIOD OF PERFORMANCE END DATE: 06/30/2028

Group Awards By:

View Award Description

Mitochondrial signaling dynamics in cocaine use disorder - PROJECT SUMMARY Cocaine use disorder continues to be a significant health burden, with psychostimulant overdose deaths rising significantly over the past few years. Cocaine exposure can alter aspects of mitochondrial function, but the tools to access and manipulate mitochondria in vivo are limited. Mitochondria contribute a significant amount of the energy required for events in the synapse in the form of adenosine triphosphate (ATP). Production of ATP in mitochondria near synapses is tightly regulated by the influx of calcium into mitochondria and leads to the generation of reactive oxygen species within the mitochondrial matrix. The studies in this proposal aim to measure and manipulate mitochondrial function, specifically calcium and hydrogen peroxide signaling in vivo, to determine how mitochondrial activity in dopamine neurons is altered in response to cocaine exposure. We will target three mitochondria-specific protein-encoding genes using a novel CRISPR viral strategy to knock out genes from dopamine neurons in DATCre mice in vivo. The target genes are involved in regulating calcium and hydrogen peroxide concentrations in mitochondria: Micu1, which is part of the mitochondrial calcium uniporter complex and allows mitochondrial calcium influx; Crls1, which encodes an enzyme necessary for the synthesis of cardiolipin, a mitochondrial phospholipid involved in integrating calcium and reactive oxygen species signaling; and Sod2, a mitochondria-specific superoxide dismutase that converts superoxide into hydrogen peroxide and enables removal of ROS from the mitochondrial matrix. Notably, Micu1 and Crls1 encode mitochondrial proteins that have been identified as targets of lead compounds, allowing for a relatively rapid determination of whether these systems can be modulated in vivo for substance use disorder treatments. To begin developing drugs for Sod2 and to refine drugs targeting Micu1 and Crls1, these studies will use mitochondrially-targeted fluorescent sensors for calcium and hydrogen peroxide in combination with fiber photometry in vivo. My preliminary evidence shows that HyPerRed, a hydrogen peroxide sensor, can be used in vivo in cortical neurons to record responses to drugs of abuse. The studies in this proposal will expand on these characterizations and further determine how cocaine may alter reactive oxygen species activity in presynaptic terminals of dopamine neurons in the nucleus accumbens core. I will also test mitochondrially- targeted GCaMP to develop a comprehensive understanding of how calcium and reactive oxygen species activity is coordinated within mitochondria. These sensors will be combined with the CRISPR viral knockout strategies and pharmacological tools targeting mitochondria to further characterize the specificity of these signals and the possible impact of these pharmacological approaches on neural function and behavior. Together, these studies will enable the exploration of a novel avenue of research by monitoring and manipulating mitochondrial function in vivo to develop treatments for cocaine use disorders.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $661,377 )
2025	2025	RESEARCH TRIANGLE INSTITUTE	3040 CORNWALLIS RD	DURHAM	NC	27709	DURHAM	USA	Drug Use and Addiction Research Programs	000	3	7/17/2025	NON-COMPETING CONTINUATION	$661,377
														Subtotal = $661,377

Issue Date FY: 2024 ( Subtotal = $663,198 )
2024	2024	RESEARCH TRIANGLE INSTITUTE	3040 CORNWALLIS RD	DURHAM	NC	27709	DURHAM	USA	Drug Use and Addiction Research Programs	000	2	6/21/2024	NON-COMPETING CONTINUATION	$663,198
														Subtotal = $663,198

Issue Date FY: 2023 ( Subtotal = $652,767 )
2023	2023	RESEARCH TRIANGLE INSTITUTE	3040 E CORNWALLIS RD	RESEARCH TRIANGLE PARK	NC	27709	DURHAM	USA	Drug Use and Addiction Research Programs	001	1	8/10/2023	NEW	$0
2023	2023	RESEARCH TRIANGLE INSTITUTE	3040 E CORNWALLIS RD	RESEARCH TRIANGLE PARK	NC	27709	DURHAM	USA	Drug Use and Addiction Research Programs	000	1	8/9/2023	NEW	$652,767
														Subtotal = $652,767

Grand Total All Awards = $1,977,342

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Mitochondrial signaling dynamics in cocaine use disorder

Award Number: DP1DA058362

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/15/2023

PERIOD OF PERFORMANCE END DATE: 06/30/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer